A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.
1,4:3,6-Dianhydro D-glucitol. Chemically inert osmotic diuretic used mainly to treat hydrocephalus; also used in glaucoma.
A direct-acting vasodilator that is used as an antihypertensive agent.
Drugs used to cause dilation of the blood vessels.
A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.
A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent.
Administration of a soluble dosage form by placement under the tongue.
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)
A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase.
A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
An ergot alkaloid (ERGOT ALKALOIDS) with uterine and VASCULAR SMOOTH MUSCLE contractile properties.
Spasm of the large- or medium-sized coronary arteries.
The veins and arteries of the HEART.
A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
A vasodilator with general properties similar to NITROGLYCERIN but with a more prolonged duration of action. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1025)
Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
Therapy with two or more separate preparations given for a combined effect.
The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.

Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. (1/325)

Glutathione S-transferases and the cytochrome P450 system have been proposed for the vascular biotransformation systems in the metabolic activation of organic nitrates. The present study was designed to elucidate the role of human cytochrome P450 isoforms on nitric oxide formation from organic nitrates using lymphoblast microsomes transfected with human CYP isoforms cDNA. CYP3A4-transfected microsomes had the most effective potential of nitric oxide formation from isosorbide dinitrate. Anti-CYP3A2 antibody (which cross-reacts with CYP3A4) or ketoconazole (an inhibitor of the CYP3A superfamily) inhibited nitric oxide formation from isosorbide dinitrate in rat heart microsomes. Immunohistochemistry of human heart also showed intense bindings of CYP3A4 antibody in the endothelium of the endocardium and coronary vessels. These results suggest that the CYP3A4-NADPH-cytochrome P450 reductase system specifically participates in nitric oxide formation from isosorbide dinitrate.  (+info)

Effect of isosorbide mononitrate on the human optic nerve and choroidal circulations. (2/325)

AIMS: To assess the effects of the nitric oxide donor 5-isosorbide mononitrate (ISMO) on blood flow in the optic nerve head (ON flow) and choroid (Ch flow). METHODS: Laser Doppler flowmetry was used to measure ON flow and Ch flow in 12 normal subjects by aiming the laser beam at the fovea and at the temporal rim, respectively. In a double masked, randomised, crossover design, each subject received orally on separate days either 20 mg of 5-isosorbide mononitrate (ISMO) or placebo. Ch flow and ON flow were determined monocularly at baseline and 1 hour after dosing. In the last six subjects, additional measurements were obtained at 3 hours. Mean arterial blood pressure (BPm), heart rate, and intraocular pressure (IOP) were monitored, and ocular perfusion pressure (PP) was estimated. RESULTS: No significant changes in ON flow, PP, IOP, or BPm were observed following placebo. Following ISMO, ON flow increased from baseline by 19.8% (SEM 9.3%) at 1 hour (paired t test, p = 0.058) and by 33.1% (7.5%) at 3 hours (p = 0.007). Compared with the changes following placebo, statistically significant increases in ON flow were observed both at 1 (p = 0.050) and 3 hours (p = 0.041) after ISMO treatment. Compared with placebo, PP decreased significantly 1 hour after ISMO dosing (p = 0.039), mainly as a function of reduced BPm. A significant inverse correlation (R = -0.618; p = 0.032) was observed between the percentage changes in PP and ON flow 1 hour following ISMO administration, but not after placebo. No significant change in foveal Ch flow was documented. CONCLUSIONS: These results suggest that, in normal subjects, ISMO increases significantly ON flow but not Ch flow. The inverse correlation observed between PP and ON flow suggests that the same mechanism(s) responsible for systemic vasodilatation and blood pressure decrease may also cause the ON flow increase.  (+info)

Matrix metalloproteinases-2 and -9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors. (3/325)

We have investigated the presence of matrix metalloproteinases (MMP)-2 and -9 and their tissue inhibitors (TIMP) in the human uterine cervix. We postulate that during the process of cervical ripening, there is an increase in the activity of MMP in order to facilitate cervical connective tissue change. We have previously demonstrated that nitric oxide (NO) donors induce cervical ripening in vivo. A secondary hypothesis is that NO donors regulate MMP activity within the human uterine cervix. Cervical tissue biopsies were obtained from both pregnant and non-pregnant subjects. Cervical fibroblasts were cultured from the non-pregnant tissue. MMP-2 was present in conditioned media from pregnant and non-pregnant cervical explants and non-pregnant cervical fibroblasts. MMP-9 secretion was only detected in explants from non-pregnant women. TIMP-1, -2 and -4 were released by all cervical explants and fibroblast preparations. Pregnant women, in the first trimester, were treated with an NO donor (isosorbide mononitrate) in vivo. Cervical explants and fibroblasts from non-pregnant women were treated with the NO donor spermine nonoate in vitro. Treatment with an NO donor either in vivo or in vitro had no effect on the secretion of the MMP or TIMP studied. Further studies evaluating the mechanisms involved in cervical ripening are required.  (+info)

Adaptive mechanisms of arterial and venous coronary bypass grafts to an increase in flow demand. (4/325)

OBJECTIVE: To compare the mechanisms by which arterial and venous grafts increase their flow during pacing induced tachycardia, early and later after coronary bypass surgery. DESIGN: 43 grafts (13 epigastric artery, 15 mammary artery, 15 saphenous vein) evaluated early (9 (3) days (mean (SD)) after bypass surgery were compared with 41 other grafts (15 epigastric, 11 mammary, 15 saphenous vein) evaluated later after surgery (mean 23 months, range 6 to 168 months) by quantitative angiography and intravascular Doppler velocity analysis during atrial pacing. Controls were 17 normal coronary arteries. RESULTS: Baseline graft flow tended to be lower later after surgery than early (41 (16) v 45 (21) ml/min, NS). Blood flow increased during pacing by 30 (16)% early after surgery, less than later after surgery (+46 (18)%, p < 0.001) and less than in normal coronary arteries (+54 (27)%, p < 0.001 v early grafts; NS v late grafts). There was no difference between venous and arterial grafts. No significant vasodilatation was observed during pacing early after surgery in arterial and venous grafts. Later after surgery, significant vasodilatation was observed only in arterial grafts (mammary and epigastric grafts), from 2.41 (0.37) to 2.53 (0. 41) mm (+5.1% v basal, p < 0.001). Early after surgery and in venous grafts later after surgery, the increase in flow was entirely due to an increase in velocity. In later arterial grafts, the relative contribution of the increase in velocity to the increase in flow during pacing was lower in arterial grafts (70 (22)%) than in venous grafts (102 (11)%, p < 0.001) and similar to normal coronary arteries (68 (28)%). CONCLUSIONS: Early and later after surgery, arterial grafts and venous grafts both increase their flow similarly during pacing. Early arterial grafts and venous grafts increase their flow only through an increase in velocity. Later after surgery, arterial grafts act as more physiological conduits and increase their flow in the same way as normal coronary arteries, through an increase in velocity and calibre mediated by the endothelium.  (+info)

Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. (5/325)

BACKGROUND: Several nonpharmacological interventions, including exercise, are recommended in primary prevention of hypertension and other cardiovascular diseases in which the pathogenetic role of endothelial dysfunction has been suggested. We studied the effects of long-term aerobic exercise on endothelial function in patients with essential hypertension. METHODS AND RESULTS: The forearm blood flow was measured by strain-gauge plethysmography. The responses of forearm vasculature to acetylcholine were smaller in the hypertensive patients than in the normotensive subjects. There was no significant difference in forearm vascular responses to isosorbide dinitrate in the normotensive and hypertensive subjects. We evaluated the effects of physical exercise for 12 weeks on forearm hemodynamics in untreated patients with mild essential hypertension who were divided randomly into an exercise group (n=10) and a control group (n=7). After 12 weeks, the forearm blood flow response to acetylcholine increased significantly, from 25.8+/-9.8 to 32.3+/-11.2 mL. min(-1). 100 mL tissue(-1) (P<0.05), in the exercise group but not in the control group. The increase in the forearm blood flow after isosorbide dinitrate was similar before and after 12 weeks of follow-up in both groups. The infusion of N(G)-monomethyl-L-arginine abolished the exercise-induced enhancement of forearm vasorelaxation evoked by acetylcholine in the exercising group. In normotensive subjects also, long-term aerobic exercise augmented acetylcholine-stimulated nitric oxide release. CONCLUSIONS: These findings suggest that long-term physical exercise improves endothelium-dependent vasorelaxation through an increase in the release of nitric oxide in normotensive as well as hypertensive subjects.  (+info)

Nitric oxide donors stimulate prostaglandin F(2alpha) and inhibit thromboxane B(2) production in the human cervix during the first trimester of pregnancy. (6/325)

Nitric oxide (NO) donors are capable of ripening the human cervix during pregnancy. The purpose of this study was to examine how NO donors may be involved in this process. Cervical biopsies were obtained from pregnant women randomized to receive isosorbide mononitrate (n = 10) or no treatment (n = 10) prior to suction termination. Enzyme-linked immunosorbent assays (ELISA) were performed on culture supernatant for interleukin (IL)-1, IL-6, IL-8, IL-10, IL-15, tumour necrosis factor-alpha, monocyte chemoattractant protein-1 and prostaglandin metabolites. Immunohistochemistry was performed to localize these cytokines, cyclooxygenase (COX)-1, COX-2 and prostaglandin dehydrogenase in cervical tissue and reverse transcription-polymerase chain reaction (RT-PCR) to identify COX-1 and COX-2 expression. Biopsies treated with the NO donor isosorbide mononitrate (IMN) produced significantly greater amounts of prostaglandin F(2alpha) in culture and lower amounts of thromboxane B(2) than controls (572.8 versus 34.9 pg/ml, P < 0.05; 53.3 pg/ml versus 530.9 pg/ml, P < 0.01 respectively). The release of other prostaglandins and of cytokines was not affected by treatment with NO. Inflammatory mediators were localized to cervical tissue and COX-1 and COX-2 expression was confirmed by RT-PCR. In conclusion, the mechanism of NO donor-induced cervical ripening during pregnancy may be mediated in part via increased prostaglandin F(2alpha) synthesis.  (+info)

Dissociation of vascular tolerance and plasma norepinephrine adjustment during long-term nitrate therapy in human coronary arteries. (7/325)

OBJECTIVE: We examined whether changes in plasma norepinephrine (NE) concentration contribute to the development of nitrate tolerance in human coronary arteries. METHODS: Patients with stable angina were randomized to receiving nitrate (isosorbide dinitrate: ISDN or nitroglycerin: TNG) infusion for 30 minutes (group A), 48 hours (group B), or 78 hours (group C). Coronary diameters were measured angiographically at baseline (CT), during maximum dilation by ISDN (N1), at the end of nitrate infusion (N2) and after additional ISDN (1 mg) injection (N3). RESULTS: In groups A and B, N1, N2, and N3 were greater than CT, and there was no significant difference between N1, N2, and N3 for each group. In group C, N1 and N3 were greater than CT, but there was no difference between CT and N2, in the development of nitrate tolerance. In group A, NE increased significantly during nitrate infusion (304+/-163 vs. 418+/-273 pg/ml). NE did not change in groups B and C. CONCLUSION: The change in NE concentration is not a primary contribution to the development of nitrate tolerance.  (+info)

Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial. (8/325)

BACKGROUND: Variceal bleeding is a severe complication of portal hypertension. Somatostatin reduces portal pressure by decreasing splanchnic blood flow, and nitrates by diminishing intrahepatic resistance. Experimental studies have shown that the combination of somatostatin and nitrates has an additive effect in decreasing portal pressure. AIM: To compare the therapeutic efficacy of either intravenous infusion of somatostatin plus oral isosorbide 5-mononitrate or somatostatin alone in gastro-oesophageal variceal bleeding associated with liver cirrhosis. METHODS: A unicentre, double blind, placebo controlled, clinical trial was conducted. Sixty patients bleeding from oesophageal or gastric varices were randomised to receive intravenous infusion of somatostatin (250 microg/hour) plus oral isosorbide 5-mononitrate (40 mg/12 hours) (group I) or somatostatin infusion plus placebo (group II) for 72 hours. RESULTS: The two groups of patients had similar clinical, endoscopic, and haematological characteristics. Control of bleeding was achieved in 18 out of 30 patients (60%) in group I and 26 out of 30 patients (87%) in group II (p<0.05). There was no significant difference in mean transfusion requirements between the two groups: 2.6 (2.2) v 1.8 (1.6) respectively; means (SD). Mortality and side effects were similar in the two groups, but development of ascites was higher in group I (30%) than in group II (7%) (p<0.05). CONCLUSION: In cirrhotic patients with acute gastro-oesophageal variceal bleeding, addition of isosorbide 5-mononitrate to somatostatin does not improve therapeutic efficacy, induces more adverse effects, and should not be used.  (+info)

Isosorbide dinitrate is a medication that belongs to a class of drugs called nitrates. It is primarily used in the prevention and treatment of angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle.

The medical definition of Isosorbide dinitrate is:

A soluble nitrate ester used in the prevention and treatment of anginal attacks. It acts by dilating coronary and peripheral arteries and veins, thereby reducing cardiac workload and increasing oxygen delivery to the heart muscle. Its therapeutic effects are attributed to its conversion to nitric oxide, a potent vasodilator, in the body. Isosorbide dinitrate is available in various forms, including tablets, capsules, and oral solutions, and is typically taken 2-3 times daily for optimal effect.

Isosorbide is a type of sugar alcohol (a sugary-tasting substance that is not actually sugar) used as a low-calorie sweetener and sugar substitute in various food and pharmaceutical products. It is also used as an active ingredient in some medications for treating chest pain (angina) and heart failure.

Medically, isosorbide can exist in two forms: isosorbide dinitrate and isosorbide mononitrate. These are both vasodilators, meaning they relax and widen blood vessels, improving blood flow and reducing the workload on the heart. Isosorbide dinitrate is often used to prevent angina attacks, while isosorbide mononitrate is used for both prevention and treatment of angina.

It's important to note that overuse of sugar alcohols like isosorbide can lead to digestive issues such as bloating, diarrhea, and gas due to their incomplete absorption in the gut.

Hydralazine is an antihypertensive medication, which means it is used to treat high blood pressure. It works by relaxing and widening the blood vessels, making it easier for the heart to pump blood through the body. This can help reduce the workload on the heart and lower blood pressure. Hydralazine is available in oral tablet form and is typically prescribed to be taken several times a day.

Hydralazine belongs to a class of medications called vasodilators, which work by relaxing the muscle in the walls of the blood vessels, causing them to widen. This increases the amount of blood that can flow through the blood vessels and reduces the pressure within them. Hydralazine is often used in combination with other medications to treat high blood pressure.

It's important to note that hydralazine should be used under the close supervision of a healthcare provider, as it can cause side effects such as headache, dizziness, and rapid heartbeat. It may also interact with certain other medications, so it is important to inform your doctor of all medications you are taking before starting hydralazine.

Vasodilator agents are pharmacological substances that cause the relaxation or widening of blood vessels by relaxing the smooth muscle in the vessel walls. This results in an increase in the diameter of the blood vessels, which decreases vascular resistance and ultimately reduces blood pressure. Vasodilators can be further classified based on their site of action:

1. Systemic vasodilators: These agents cause a generalized relaxation of the smooth muscle in the walls of both arteries and veins, resulting in a decrease in peripheral vascular resistance and preload (the volume of blood returning to the heart). Examples include nitroglycerin, hydralazine, and calcium channel blockers.
2. Arterial vasodilators: These agents primarily affect the smooth muscle in arterial vessel walls, leading to a reduction in afterload (the pressure against which the heart pumps blood). Examples include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and direct vasodilators like sodium nitroprusside.
3. Venous vasodilators: These agents primarily affect the smooth muscle in venous vessel walls, increasing venous capacitance and reducing preload. Examples include nitroglycerin and other organic nitrates.

Vasodilator agents are used to treat various cardiovascular conditions such as hypertension, heart failure, angina, and pulmonary arterial hypertension. It is essential to monitor their use carefully, as excessive vasodilation can lead to orthostatic hypotension, reflex tachycardia, or fluid retention.

Ergoloid mesylates are a type of medication that is used to treat symptoms of dementia, particularly in the elderly. They are a combination of several ergot alkaloids, which are derived from a type of fungus called Claviceps purpurea. These alkaloids have been chemically modified to create a preparation that can help improve cognitive function and reduce confusion in people with dementia.

Ergoloid mesylates work by stimulating certain receptors in the brain, which can help improve blood flow and increase the availability of oxygen and nutrients to brain cells. This can help improve mental clarity, memory, and overall cognitive function. The medication can also help reduce agitation and aggression in people with dementia.

Ergoloid mesylates are typically prescribed in low doses and are taken orally, usually several times a day. Common side effects of the medication include dizziness, headache, nausea, and vomiting. In some cases, ergoloid mesylates may interact with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting this treatment.

It's worth noting that the use of ergoloid mesylates for dementia has been a subject of controversy in recent years, as some studies have suggested that they may not be effective in improving cognitive function or reducing behavioral symptoms. Therefore, it is important to discuss the potential benefits and risks of this medication with your healthcare provider before deciding whether to use it.

I'm sorry for any confusion, but "Oxyfedrine" does not appear to be a valid or recognized medication or substance in modern medicine. It's possible that there may be a spelling error or it could be an outdated or obsolete term. Please provide more context or check the spelling so I can give you a more accurate and helpful response.

Sublingual administration refers to a route of delivering medication or other substances through placement under the tongue, allowing for rapid absorption into the bloodstream through the mucous membranes located there. This method can allow for quick onset of action and avoids first-pass metabolism in the liver that may occur with oral administration. Common examples of sublingual medications include nitroglycerin for angina pectoris and certain forms of hormone replacement therapy.

Nitric oxide (NO) donors are pharmacological agents that release nitric oxide in the body when they are metabolized. Nitric oxide is a molecule that plays an important role as a signaling messenger in the cardiovascular, nervous, and immune systems. It helps regulate blood flow, relax smooth muscle, inhibit platelet aggregation, and modulate inflammatory responses.

NO donors can be used medically to treat various conditions, such as hypertension, angina, heart failure, and pulmonary hypertension, by promoting vasodilation and improving blood flow. Some examples of NO donors include nitroglycerin, isosorbide dinitrate, sodium nitroprusside, and molsidomine. These drugs work by releasing nitric oxide slowly over time, which then interacts with the enzyme soluble guanylate cyclase to produce cyclic guanosine monophosphate (cGMP), leading to relaxation of smooth muscle and vasodilation.

It is important to note that NO donors can have side effects, such as headache, dizziness, and hypotension, due to their vasodilatory effects. Therefore, they should be used under the guidance of a healthcare professional.

Nicorandil is a medication that belongs to a class of drugs known as potassium channel activators. It works by relaxing and widening blood vessels, which improves blood flow and reduces the workload on the heart. Nicorandil is primarily used to treat chronic stable angina, a type of chest pain caused by reduced blood flow to the heart muscle.

The medical definition of Nicorandil can be described as:

A synthetic derivative of nicotinamide with vasodilatory properties, acting as an opener of ATP-sensitive potassium channels in vascular smooth muscle and cardiomyocytes. It is used in the management of chronic stable angina, providing both antianginal and antiischemic effects through a dual mechanism that includes coronary and peripheral vasodilation. By reducing afterload and preload, Nicorandil decreases myocardial oxygen demand while increasing supply, leading to improved exercise tolerance and reduced frequency of anginal episodes.

Angina pectoris, variant (also known as Prinzmetal's angina or vasospastic angina) is a type of chest pain that results from reduced blood flow to the heart muscle due to spasms in the coronary arteries. These spasms cause the arteries to narrow, temporarily reducing the supply of oxygen-rich blood to the heart. This can lead to symptoms such as chest pain, shortness of breath, and fatigue.

Variant angina is typically more severe than other forms of angina and can occur at rest or with minimal physical exertion. It is often treated with medications that help relax the coronary arteries and prevent spasms, such as calcium channel blockers and nitrates. In some cases, additional treatments such as angioplasty or bypass surgery may be necessary to improve blood flow to the heart.

It's important to note that chest pain can have many different causes, so it is essential to seek medical attention if you experience any symptoms of angina or other types of chest pain. A healthcare professional can help determine the cause of your symptoms and develop an appropriate treatment plan.

Nitroglycerin, also known as glyceryl trinitrate, is a medication used primarily for the treatment of angina pectoris (chest pain due to coronary artery disease) and hypertensive emergencies (severe high blood pressure). It belongs to a class of drugs called nitrates or organic nitrites.

Nitroglycerin works by relaxing and dilating the smooth muscle in blood vessels, which leads to decreased workload on the heart and increased oxygen delivery to the myocardium (heart muscle). This results in reduced symptoms of angina and improved cardiac function during hypertensive emergencies.

The drug is available in various forms, including sublingual tablets, sprays, transdermal patches, ointments, and intravenous solutions. The choice of formulation depends on the specific clinical situation and patient needs. Common side effects of nitroglycerin include headache, dizziness, and hypotension (low blood pressure).

Angina pectoris is a medical term that describes chest pain or discomfort caused by an inadequate supply of oxygen-rich blood to the heart muscle. This condition often occurs due to coronary artery disease, where the coronary arteries become narrowed or blocked by the buildup of cholesterol, fatty deposits, and other substances, known as plaques. These blockages can reduce blood flow to the heart, causing ischemia (lack of oxygen) and leading to angina symptoms.

There are two primary types of angina: stable and unstable. Stable angina is predictable and usually occurs during physical exertion or emotional stress when the heart needs more oxygen-rich blood. The pain typically subsides with rest or after taking prescribed nitroglycerin medication, which helps widen the blood vessels and improve blood flow to the heart.

Unstable angina, on the other hand, is more severe and unpredictable. It can occur at rest, during sleep, or with minimal physical activity and may not be relieved by rest or nitroglycerin. Unstable angina is considered a medical emergency, as it could indicate an imminent heart attack.

Symptoms of angina pectoris include chest pain, pressure, tightness, or heaviness that typically radiates to the left arm, neck, jaw, or back. Shortness of breath, nausea, sweating, and fatigue may also accompany angina symptoms. Immediate medical attention is necessary if you experience chest pain or discomfort, especially if it's new, severe, or persistent, as it could be a sign of a more serious condition like a heart attack.

Ergonovine is a medication that belongs to a class of drugs called ergot alkaloids. It is derived from the ergot fungus and is used in medical settings as a uterotonic agent, which means it causes the uterus to contract. Ergonovine is often used after childbirth to help the uterus return to its normal size and reduce bleeding.

Ergonovine works by binding to specific receptors in the smooth muscle of the uterus, causing it to contract. It has a potent effect on the uterus and can also cause vasoconstriction (narrowing of blood vessels) in other parts of the body. This is why ergonovine is sometimes used to treat severe bleeding caused by conditions such as uterine fibroids or ectopic pregnancy.

Like other ergot alkaloids, ergonovine can have serious side effects if not used carefully. It should be administered under the close supervision of a healthcare provider and should not be used in women with certain medical conditions, such as high blood pressure or heart disease. Ergonovine can also interact with other medications, so it's important to inform your healthcare provider of all medications you are taking before receiving this drug.

Coronary vasospasm refers to a sudden constriction (narrowing) of the coronary arteries, which supply oxygenated blood to the heart muscle. This constriction can reduce or block blood flow, leading to symptoms such as chest pain (angina) or, in severe cases, a heart attack (myocardial infarction). Coronary vasospasm can occur spontaneously or be triggered by various factors, including stress, smoking, and certain medications. It is also associated with conditions such as coronary artery disease and variant angina. Prolonged or recurrent vasospasms can cause damage to the heart muscle and increase the risk of cardiovascular events.

Coronary vessels refer to the network of blood vessels that supply oxygenated blood and nutrients to the heart muscle, also known as the myocardium. The two main coronary arteries are the left main coronary artery and the right coronary artery.

The left main coronary artery branches off into the left anterior descending artery (LAD) and the left circumflex artery (LCx). The LAD supplies blood to the front of the heart, while the LCx supplies blood to the side and back of the heart.

The right coronary artery supplies blood to the right lower part of the heart, including the right atrium and ventricle, as well as the back of the heart.

Coronary vessel disease (CVD) occurs when these vessels become narrowed or blocked due to the buildup of plaque, leading to reduced blood flow to the heart muscle. This can result in chest pain, shortness of breath, or a heart attack.

Captopril is a medication that belongs to a class of drugs called ACE (angiotensin-converting enzyme) inhibitors. It works by blocking the action of a chemical in the body called angiotensin II, which causes blood vessels to narrow and release hormones that can increase blood pressure. By blocking the action of angiotensin II, captopril helps relax and widen blood vessels, which lowers blood pressure and improves blood flow.

Captopril is used to treat high blood pressure (hypertension), congestive heart failure, and to improve survival after a heart attack. It may also be used to protect the kidneys from damage due to diabetes or high blood pressure. The medication comes in the form of tablets that are taken by mouth, usually two to three times per day.

Common side effects of captopril include cough, dizziness, headache, and skin rash. More serious side effects may include allergic reactions, kidney problems, and changes in blood cell counts. It is important for patients taking captopril to follow their doctor's instructions carefully and report any unusual symptoms or side effects promptly.

Pentaerythritol Tetranitrate (PETN) is a powerful explosive substance, rather than a medical term. However, it can be used in a medical context as an active ingredient in certain prescription medications.

Medically, Pentaerythritol Tetranitrate is classified as a nitrate vasodilator. It works by relaxing and widening blood vessels, which allows for increased oxygen delivery and improved blood flow, particularly to the heart muscle. This can help reduce the workload on the heart and alleviate symptoms of angina (chest pain) caused by coronary artery disease.

It is available in various forms, such as extended-release tablets or sublingual (under-the-tongue) tablets, under brand names like Nitrolingual®, Nitrostat®, and Pentaerythritol Tetranitrate ER®.

Please consult a healthcare professional for more information about this medication and its uses.

Nitrates are chemical compounds that consist of a nitrogen atom bonded to three oxygen atoms (NO3-). In the context of medical science, nitrates are often discussed in relation to their use as medications or their presence in food and water.

As medications, nitrates are commonly used to treat angina (chest pain) caused by coronary artery disease. Nitrates work by relaxing and widening blood vessels, which improves blood flow and reduces the workload on the heart. Some examples of nitrate medications include nitroglycerin, isosorbide dinitrate, and isosorbide mononitrate.

In food and water, nitrates are naturally occurring compounds that can be found in a variety of vegetables, such as spinach, beets, and lettuce. They can also be present in fertilizers and industrial waste, which can contaminate groundwater and surface water sources. While nitrates themselves are not harmful, they can be converted into potentially harmful compounds called nitrites under certain conditions, particularly in the digestive system of young children or in the presence of bacteria such as those found in unpasteurized foods. Excessive levels of nitrites can react with hemoglobin in the blood to form methemoglobin, which cannot transport oxygen effectively and can lead to a condition called methemoglobinemia.

Molsidomine is a medication that belongs to a class of drugs called vasodilators. It works by relaxing and widening blood vessels, which helps to improve blood flow and reduce the workload on the heart. Molsidomine is used to treat chronic stable angina (chest pain caused by reduced blood flow to the heart) and has been found to be effective in reducing the frequency and severity of anginal attacks.

When molsidomine is absorbed into the body, it is converted into its active metabolite, SIN-1, which is responsible for its vasodilatory effects. SIN-1 causes smooth muscle relaxation by increasing the levels of nitric oxide in the blood vessels, leading to their dilation and improved blood flow.

Molsidomine is available in tablet form and is typically taken two to three times a day, with or without food. Common side effects of molsidomine include headache, dizziness, flushing, and palpitations. It should be used with caution in patients with low blood pressure, heart failure, or impaired kidney function.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Vasodilation is the widening or increase in diameter of blood vessels, particularly the involuntary relaxation of the smooth muscle in the tunica media (middle layer) of the arteriole walls. This results in an increase in blood flow and a decrease in vascular resistance. Vasodilation can occur due to various physiological and pathophysiological stimuli, such as local metabolic demands, neural signals, or pharmacological agents. It plays a crucial role in regulating blood pressure, tissue perfusion, and thermoregulation.

... is in the nitrate family of medications and works by dilating blood vessels. Isosorbide dinitrate was ... Isosorbide dinitrate is sold in the US under the brand names Dilatrate-SR by Schwarz and Isordil by Valeant, according to FDA ... Isosorbide dinitrate is available as a generic medication. A long-acting form exists. In 2020, it was the 299th most commonly ... Isosorbide dinitrate is a medication used for heart failure, esophageal spasms, and to treat and prevent chest pain from not ...
"Isosorbide Dinitrate/Mononitrate Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. ... "Isosorbide - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022. "Monoket- isosorbide mononitrate tablet". DailyMed. 3 ... Isosorbide mononitrate is a nitrate-class drug used for the prevention of angina pectoris. The sublingual patch has an onset of ... Isosorbide mononitrate, sold under many brand names, is a medication used for heart-related chest pain (angina), heart failure ...
"BiDil (isosorbide dinitrate/hydralazine HCl) Heart Failure Medication". www.bidil.com. Retrieved 2022-02-24. Sankar, Pamela; ...
"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure". The New England Journal of Medicine. 351 (20 ...
Agents include glyceryl trinitrate (GTN), pentaerythritol tetranitrate, isosorbide dinitrate and isosorbide mononitrate. Beta ...
2004). "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure". N Engl J Med. 351 (20): 2049-57. doi ... The combination of isosorbide dinitrate/hydralazine is the only vasodilator regimen, other than ACE inhibitors or angiotensin ...
This preparation, isosorbide dinitrate/hydralazine, was the first race-based prescription drug. It should not be used in people ... It has been found to be particularly useful in heart failure, together with isosorbide dinitrate, for treatment of people of ... Hydralazine is commonly used in combination with isosorbide dinitrate for the treatment of congestive heart failure in black ... July 2014). "Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African- ...
Russek H. I. (1966). "The therapeutic role of coronary vasodilators: glyceryl trinitrate, isosorbide dinitrate, and ... Some bacteria denitrate PETN to trinitrate and then dinitrate, which is then further degraded. PETN has low volatility and low ... Water at 100 °C or above causes hydrolysis to dinitrate; presence of 0.1% nitric acid accelerates the reaction. The chemical ... Neutron radiation degrades PETN, producing carbon dioxide and some pentaerythritol dinitrate and trinitrate. Gamma radiation ...
By nitration of isosorbide with concentrated nitric acid, 2,5-isosorbide dinitrate (ISDN) can be obtained. 2,5-isosorbide ... By reacting isosorbide with epichlorohydrin, isosorbide bis-glycidyl ether (a bis-epoxide) is formed, which could be used as a ... Esterification of isosorbide with fatty acids gives access to isosorbide monoesters, which are useful as detergents in ... Phosphorus-based isosorbide compounds, such as isosorbide bis (diphenyl phosphate) [ISTP] are considered as a replacement. ISTP ...
These include calcium channel blockers such as nifedipine and nitrates such as isosorbide dinitrate and nitroglycerin. However ...
Nitrate medications, including isosorbide dinitrate, given before meals, may also help relax the LES and improve symptoms. The ...
Animal studies have shown that vasodilators, such as papaverine and isosorbide dinitrate, can be used as antidotes. The animal ...
November 1998). "Indomethacin increases the effect of isosorbide dinitrate on cerebral hemodynamic in migraine patients: ...
... which includes many other nitrates like isosorbide dinitrate (Isordil) and isosorbide mononitrate (Imdur, Ismo, Monoket). These ... Ethylene glycol dinitrate or another polynitrate may be added to lower the melting point and thereby avoid the necessity of ... Erythritol tetranitrate Ethylene glycol dinitrate Mannitol hexanitrate Methyl nitrate Tetranitratoxycarbon Xylitol pentanitrate ...
The nitrate esters isosorbide dinitrate (Isordil) and isosorbide mononitrate (Imdur, Ismo, Monoket, Mononitron) are converted ...
... or nitrate medications such as isosorbide mononitrate or isosorbide dinitrate. Concurrent use of these medications can lead to ...
... isosorbide dinitrate) or short-acting (i.e. nitroglycerin) durations of action. These drugs work by increasing nitric oxide ...
... nitroglycerin isosorbide mononitrate isosorbide dinitrate sodium nitroprusside alkyl nitrites (commonly known as "poppers") ...
... isosorbide MeSH D09.853.813.480.500 - isosorbide dinitrate MeSH D09.853.813.550 - meglumine MeSH D09.853.813.550.500 - ...
C01DA07 Propatylnitrate C01DA08 Isosorbide dinitrate C01DA09 Trolnitrate C01DA13 Eritrityl tetranitrate C01DA14 Isosorbide ... combinations C01DA58 Isosorbide dinitrate, combinations C01DA59 Trolnitrate, combinations C01DA63 Eritrityl tetranitrate, ... combinations C01DA54 Methylpropylpropanediol dinitrate, combinations C01DA55 Pentaerithrityl tetranitrate, combinations C01DA57 ... Xamoterol C01CX08 Levosimendan C01CX09 Angiotensin II C01DA02 Glyceryl trinitrate C01DA04 Methylpropylpropanediol dinitrate ...
Some of these landmark trials include: V-HeFT (1986) - use of vasodilators (hydralazine & isosorbide dinitrate) in heart ...
Isoptin Isopto Cetamide Isopto Cetapred Isordil isosorbide dinitrate (INN) isosorbide mononitrate (INN) isosorbide (INN) ... Redirects to isosorbide mononitrate. isoniazid (INN) isonixin (INN) Isopaque isophane insulin (INN) isoprazone (INN) ...
Coagulation factor VIIIα Coagulation factor IXα Dextran 70 Bisoprolol Glyceryl trinitrate Isosorbide dinitrate Verapamil ...
... isosorbide MeSH D02.033.800.813.480.500 - isosorbide dinitrate MeSH D02.033.800.813.550 - meglumine MeSH D02.033.800.813. ...
Cinchocaine C05AD05 Procaine C05AD06 Oxetacaine C05AD07 Pramocaine C05AE01 Glyceryl trinitrate C05AE02 Isosorbide dinitrate ...
Long-acting nitroglycerins such as isosorbide dinitrate or intermittent use of short-acting nitroglycerin (to treat acute ...
... isosorbide mononitrate and isosorbide dinitrate pentaerythritol tetranitrate (PETN) sodium nitroprusside PDE5 inhibitors: these ...
... such as isosorbide dinitrate, is an effective alternate strategy. This regimen has been shown to reduce mortality in people ...
Sublingual and chewable forms of isosorbide dinitrate in dosage strengths of 10 mg or less. Erythromycin ethylsuccinate ...
... by The Future Sound of London Isosorbide dinitrate, the drug used in the treatment of angina pectoris This disambiguation page ...
Isosorbide dinitrate is in the nitrate family of medications and works by dilating blood vessels. Isosorbide dinitrate was ... Isosorbide dinitrate is sold in the US under the brand names Dilatrate-SR by Schwarz and Isordil by Valeant, according to FDA ... Isosorbide dinitrate is available as a generic medication. A long-acting form exists. In 2020, it was the 299th most commonly ... Isosorbide dinitrate is a medication used for heart failure, esophageal spasms, and to treat and prevent chest pain from not ...
ISOSORBIDE DINITRATE (UNII: IA7306519N) (ISOSORBIDE DINITRATE - UNII:IA7306519N) ISOSORBIDE DINITRATE. 5 mg. ... ISOSORBIDE DINITRATE (UNII: IA7306519N) (ISOSORBIDE DINITRATE - UNII:IA7306519N) ISOSORBIDE DINITRATE. 10 mg. ... ISOSORBIDE DINITRATE (UNII: IA7306519N) (ISOSORBIDE DINITRATE - UNII:IA7306519N) ISOSORBIDE DINITRATE. 20 mg. ... Isosorbide dinitrate tablets are contraindicated in patients who are allergic to isosorbide dinitrate or any of its other ...
ISOSORBIDE DINITRATE (UNII: IA7306519N) (ISOSORBIDE DINITRATE - UNII:IA7306519N) ISOSORBIDE DINITRATE. 40 mg. ... isosorbide dinitrate 40 MG Extended Release Oral Tablet. PSN. 2. 311194. isosorbide dinitrate 40 MG Extended Release Oral ... Isosorbide dinitrate is available as 40 mg extended-release tablets. The chemical name for isosorbide dinitrate is 1 ,4:3,6- ... Each Isosorbide Dinitrate Extended-release tablet, for oral administration, contains 40 mg of isosorbide dinitrate, in a matrix ...
Isosorbide Dinitrate 20 mg*Capsules, Retard; Oral; Isosorbide Dinitrate 40 mg*Capsules, Retard; Oral; Isosorbide Dinitrate 60 ... C01DA08 - Isosorbide Dinitrate*C05AE02 - Isosorbide Dinitrate. Pharmaceutical companies: manufacturers, researchers, developers ...
Isosorbide Dinitrate Sublingual Tablet 2.5 mg, 5 mg Isosorbide Dinitrate Sublingual Tablet 2.5 mg, 5 mg. This medicine is used ...
Free coupons for isosorbide dinitrate/hydralazine (bidil). Discounts up to 80% off the retail price. ... Compare Isosorbide dinitrate/hydralazine (bidil) 20/37.5 mg prices from verified online pharmacies or local U.S. pharmacies. ... Imdur, Ismo, Isosorbide Dinitrate, Isosorbide Mononitrate, Isosorbide Mononitrate ER, Isosorbide Mononitrate SR ... Isosorbide dinitrate/hydralazine Prices - (Bidil) Compare Isosorbide Dinitrate/Hydralazine (Bidil) prices available at Canadian ...
Isosorbide Dinitrate- Store in a cool, dry place (room temperature), away from light and children. Throw away all expired ... Isosorbide Dinitrate - Handling. How should I handle Isosorbide Dinitrate safely?. Isosorbide Dinitrate - Storage. How should I ... How should I dispose of Isosorbide Dinitrate safely?. ​Pack this medication into a black trash bag and seal it tightly before ... Isosorbide Dinitrate ?. ;#Keep away from children;#Keep in a cool, dry place, away from direct sunlight;# ​Throw away all ...
... isosorbide dinitrate), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation ... isosorbide dinitrate oral ISOSORBIDE DINITRATE - ORAL (EYE-soe-SOR-bide dye-NYE-trate) COMMON BRAND NAME(S): Isordil USES: ... encoded search term (isosorbide dinitrate (Dilatrate-SR%2C Isordil)) and isosorbide dinitrate (Dilatrate-SR, Isordil) What to ... Isosorbide dinitrate is very similar to isosorbide mononitrate. Do not use medications containing isosorbide mononitrate while ...
We studied 1 people who take Isosorbide dinitrate and hydralazine hydrochloride from the FDA. Side effects are found. See what ... isosorbide dinitrate (the active ingredients of Isosorbide dinitrate and hydralazine hydrochloride) and Isosorbide dinitrate ... Isosorbide dinitrate and hydralazine hydrochloride has active ingredients of hydralazine hydrochloride; isosorbide dinitrate. ... Alternative drugs to, pros and cons of Isosorbide dinitrate and hydralazine hydrochloride:. *Isosorbide dinitrate and ...
Characterization of Hemodynamic Response to Isosorbide Dinitrate During Chronic Administration in Patients with Chronic Stable ... "Characterization of Hemodynamic Response to Isosorbide Dinitrate During Chronic Administration in Patients with Chronic Stable ...
If you are also looking for Isosorbide Dinitrate Tablets such as Isosorbide Dinitrate 10 mg tablet, Isosorbide Dinitrate 20 mg ... Hypersensitivity to Isosorbide Dinitrate is a contraindication. In addition, Isosorbide Dinitrate should not be used if you ... Isosorbide Dinitrate is used for Severe Chest Pain, Congestive Cardiac Failure and other conditions.Isosorbide Dinitrate ... The following is a list of possible side-effects that may occur in medicines that contain Isosorbide Dinitrate. This is not a ...
Since 2010, Ingenus has developed, manufactured and commercialized quality generic medications as cost effective solutions for patients, suppliers and stakeholders across the healthcare continuum. Ingenus has improved patient access, offset healthcare costs and maintained high quality standards that we have become known for ...
2018 / Isosorbide dinitrate Isosorbide dinitrate. Injection 1 mg/ ml N/A Tablet 10 mg Tablet 5 mg Tablet 30 mg Tablet 40 mg ...
Isordil is contraindicated in patients who have allergy to isosorbide dinitrate or any of its other ingredients although ... an unusual or allergic reaction to isosorbide dinitrate, nitrates, other medicines, foods, dyes, or preservatives, you pregnant ...
This is a fixed-dose combination of isosorbide dinitrate (20 mg/tab), a vasodilator with effects on both arteries and veins, ... Isosorbide dinitrate relaxes vascular smooth muscle by stimulating intracellular cyclic GMP. It decreases left ventricular ... Chronic use of isosorbide dinitrate as a sole vasodilating agent is not recommended. ... Isosorbide mononitrate causes relaxation of vascular smooth muscle and consequent dilatation of peripheral arteries and veins. ...
Catchable fatal error: Object of class WP_Error could not be converted to string in /home/platne/serwer22598/public_html/abanfund.vc/wp-content/themes/reka/inc/breadcrumbs.php on line 98 ...
Kjøpe Billig Isosorbide Dinitrate Med Resept. Kjøpe Piller Isosorbide Dinitrate Uten Forsikring. Lav Pris Isosorbide Dinitrate ... Over Disk Isosorbide Dinitrate Apotek 24h Bergen. Uten Rx Isosorbide Dinitrate Tromsø. Bestill Isosorbide Dinitrate Apotek ... Godkjent Apotek Isosorbide Dinitrate. Kjøpe Piller Isosorbide Dinitrate Gratis Frakt. Over Disk Isosorbide Dinitrate ... Kjøp Generic Isosorbide Dinitrate Rask Levering. Hvor Får Man Kjøpt Isosorbide Dinitrate Rask Levering. Ekte Isosorbide ...
Also Known As: Isosorbide dinitrate, Dilatrate sr, Dilatrate, Isordil, Sorbitrate. Isosorbide dinitrate (ISDN) (also known as ... Isosorbide dinitrate is sold under the brand names Isordil by Biovail, Cedocard, Sorbitrate and Isotrate. In UK, Argentina and ... Complete a survey on Isosorbide dinitrate to help the CureCrowd community. If you have tried to treat this ailment, please ...
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice ...
isosorbide dinitrate. Inventory. EC number:. 201-740-9. EC name:. Isosorbide dinitrate. CAS number:. 87-33-2. CAS number:. 87- ... 3R,3aS,6S,6aS)-hexahydrofuro[3,2-b]furan-3,6-diyl dinitrate. Molecular and structural information. Molecular formula:. C6H8N2O8 ...
ISOSORBIDE DINITRATE MIXTURE with not less than 60% lactose, mannose, starch or calcium hydrogen phosphate ... ISOSORBIDE DINITRATE MIXTURE with not less than 60% lactose, mannose, starch or calcium hydrogen phosphate. ... ISOSORBIDE DINITRATE MIXTURE with not less than 60% lactose, mannose, starch or calcium hydrogen phosphate. ...
... isosorbide dinitrate) from The Canadian Pharmacy and save! A fully licensed CIPA certified online pharmacy. ... Isordil is available as a sublingual tablet containing 2.5 mg or 5 mg isosorbide dinitrate. Isordil 2.5 mg tablets are round, ... Isordil is comprised of the active ingredient isosorbide dinitrate. Other inactive ingredients include cellulose, lactose, ... You should not take Isordil if you are allergic to isosorbide dinitrate. ...
Isosorbide Dinitrate. Isosorbide Dinitrate. Isosorbide Dinitrate is a Oral Tablet in the Human Prescription Drug category. It ... NDC Crossover Matching brand name "Isosorbide Dinitrate" or generic name "Isosorbide Dinitrate". NDC. Brand Name. Generic Name ... Isosorbide Dinitrate. Isosorbide Dinitrate. 0143-1767. Isosorbide Dinitrate. Isosorbide Dinitrate. 0143-1769. Isosorbide ... Isosorbide Dinitrate. 0143-1771. Isosorbide Dinitrate. Isosorbide Dinitrate. 0143-1772. Isosorbide Dinitrate. Isosorbide ...
Isosorbide dinitrate is available as 40 mg extended-release tablets. The chemical name for isosorbide dinitrate is 1,4:3,6- ... Each Isosorbide Dinitrate Extended-release tablet, for oral administration, contains 40 mg of isosorbide dinitrate, in a matrix ... Isosorbide Dinitrate Extended-release Tablets are contraindicated in patients who are allergic to isosorbide dinitrate or to ... ISOSORBIDE DINITRATE. Extended-release Tablets, USP. Home/ISOSORBIDE DINITRATEExtended-release Tablets, USP ...
Isordil (isosorbide dinitrate). Headache, dizziness, low blood. pressure. Lopressor (metroprolol tartrate). Depression, ... Commonly used antiangina drugs include isosorbide dinitrate (Isordil, Sorbitrate, and other brands) and nitroglycerin (Nitro- ...
The effect of isosorbide dinitrate on the pulmonary arterial system in patients with pulmonary hypertension. In: Respiration ... The effect of isosorbide dinitrate on the pulmonary arterial system in patients with pulmonary hypertension. / Hoshino, T.; ... Hoshino T, Handa S, Akizuki S, Hori S. The effect of isosorbide dinitrate on the pulmonary arterial system in patients with ... The effect of isosorbide dinitrate on the pulmonary arterial system in patients with pulmonary hypertension. ...
The effectiveness of tenoxicam vs isosorbide dinitrate plus tenoxicam in the treatment of acute renal colic ... Objective To determine the effectiveness of isosorbide dinitrate in combination with tenoxicam compared with tenoxicam alone ...
Isosorbide Dinitrate (Isordil, Diltrate) Isosorbide Mononitrate (Ismo, Monoket) Nitroglycerin, Translingual (Nitrostat, ...
0.5 mg dinitrate isosorbide (group LN). The primary endpoint was the duration of radial puncture (from beginning of local ...
  • Isosorbide dinitrate is sold in the US under the brand names Dilatrate-SR by Schwarz and Isordil by Valeant, according to FDA Orange Book. (wikipedia.org)
  • Isordil is contraindicated in patients who have allergy to isosorbide dinitrate or any of its other ingredients although allergic reactions to organic nitrates are extremely rare, but they do occur sometimes. (awccanadianpharmacy.org)
  • Isosorbide dinitrate is sold under the brand names Isordil by Biovail , Cedocard, Sorbitrate and Isotrate. (curecrowd.com)
  • Order Isordil 2.5,5 mg Tablets (isosorbide dinitrate) from Canada & Save! (thecanadianpharmacy.com)
  • Similar to other nitrites and organic nitrates, isosorbide dinitrate is converted to nitric oxide (NO), an active intermediate compound which activates the enzyme guanylate cyclase (atrial natriuretic peptide receptor A). This stimulates the synthesis of cyclic guanosine 3',5'-monophosphate (cGMP) which then activates a series of protein kinase-dependent phosphorylations in the smooth muscle cells, eventually resulting in the dephosphorylation of the myosin light chain of the smooth muscle fiber. (wikipedia.org)
  • Your doctor needs to know if you have previous heart attack or heart failure, an unusual or allergic reaction to isosorbide dinitrate, nitrates, other medicines, foods, dyes, or preservatives, you pregnant or trying to get pregnant or you are breast-feeding. (awccanadianpharmacy.org)
  • With an overall half-life of about 5 hours, the 5-mononitrate is cleared from the serum by denitration to isosorbide, glucuronidation to the 5-mononitrate glucuronide, and denitration/hydration to sorbitol. (nih.gov)
  • Isosorbide dinitrate is available as 40 mg extended-release tablets. (nih.gov)
  • it is not known whether similar increases in bioavailability appear during the course of chronic therapy with Isosorbide Dinitrate Extended-release Tablets. (nih.gov)
  • Actiza Pharmaceutical is a genuine supplier, wholesaler, manufacturers and exporters of isosorbide dinitrate tablets. (actizapharma.com)
  • If you are also looking for Isosorbide Dinitrate Tablets such as Isosorbide Dinitrate 10 mg tablet, Isosorbide Dinitrate 20 mg tablet then you can feel free to contact us. (actizapharma.com)
  • Conformance of Isosorbide Dinitrate Extended-release Tablets with the USP release test is pending. (prescriptiondrugs.com)
  • Isosorbide Dinitrate Extended-release Tablets are indicated for the prevention of angina pectoris due to coronary artery disease. (prescriptiondrugs.com)
  • Isosorbide Dinitrate Extended-release Tablets are contraindicated in patients who are allergic to isosorbide dinitrate or to any of its other ingredients. (prescriptiondrugs.com)
  • Compare Isosorbide Dinitrate/Hydralazine (Bidil) prices available at Canadian and international online pharmacies with local U.S. pharmacy coupon prices. (pharmacychecker.com)
  • Isosorbide and hydralazine in a fixed-dose combination (BiDil) has provoked controversy as the first drug approved by the Food and Drug Administration marketed for a single racial-ethnic group, African Americans, in the treatment of congestive heart failure. (annfammed.org)
  • Family physicians have no doubt been approached by their African American patients with congestive heart failure (and perhaps with other heart diseases), asking about the new "for blacks only" medicine, isosorbide dinitrate and hydralazine hydrochloride (BiDil). (annfammed.org)
  • Side effects are reported by people who take Isosorbide dinitrate and hydralazine hydrochloride. (ehealthme.com)
  • 1 person who takes Isosorbide Dinitrate And Hydralazine Hydrochloride and has side effects is studied. (ehealthme.com)
  • What is Isosorbide Dinitrate And Hydralazine Hydrochloride? (ehealthme.com)
  • Currently, eHealthMe is studying from 1 Isosorbide dinitrate and hydralazine hydrochloride user. (ehealthme.com)
  • Do you take Isosorbide dinitrate and hydralazine hydrochloride? (ehealthme.com)
  • the active ingredients of Isosorbide dinitrate and hydralazine hydrochloride) and Isosorbide dinitrate and hydralazine hydrochloride (the brand name). (ehealthme.com)
  • Isosorbide acts as a nitric oxide donor and hydralazine as an antioxidant, and so together they might ameliorate the long-term effects of heart failure. (annfammed.org)
  • A combination of isosorbide and hydralazine (160 mg and 300 mg total daily dose, respectively) was compared with enalapril (20 mg) in the second Vasodilator-Heart Failure Trial. (annfammed.org)
  • A later retrospective review of those data, however, found that white patients had disproportionate benefit from enalapril, whereas the subset of African American patients appeared to receive substantially more benefit from the isosorbide-hydralazine therapy. (annfammed.org)
  • 6 As of this point, no one had yet tested the hypothesis that isosorbide and hydralazine, added to a regimen that already included an angiotensin-converting enzyme (ACE) inhibitor, might provide benefit to patients with congestive heart failure. (annfammed.org)
  • About 1,000 patients were randomized to a fixed-dose combination of isosorbide and hydralazine (target daily dose, 120 mg and 225 mg, respectively) or placebo added to their existing medications (69% were on ACE inhibitors at baseline). (annfammed.org)
  • Isosorbide dinitrate (ISDN), an organic nitrate, is a vasodilator with effects on both arteries and veins. (nih.gov)
  • Isosorbide dinitrate (ISDN) (also known as Dilatrate) is a nitrate used pharmacologically as a vasodilator , e.g. in angina pectoris but also for anal fissure , a condition which is known to involve decreased blood supply leading to poor healing. (curecrowd.com)
  • Dizabol had a more significant relaxant effect than 10-5 M isosorbide dinitrate (ISDN). (bvsalud.org)
  • isosorbide dinitrate, sildenafil. (medscape.com)
  • Amplification of the vasodilatory effects of isosorbide dinitrate by sildenafil can result in severe hypotension. (prescriptiondrugs.com)
  • Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris. (naturalnews.com)
  • Eighty-four consecutive patients undergoing coronary procedures using radial approach were randomly assigned between two types of local anesthesia (double blind): 5 ml lidocaine (group L)-5 ml lidocaine + 0.5 mg dinitrate isosorbide (group LN). The primary endpoint was the duration of radial puncture (from beginning of local anesthesia to sheath insertion) and the total number of punctures. (nih.gov)
  • During coronary angiography, 15 μg of acetylcholine and 0.5 mg isosorbide dinitrate were infused into the coronary artery. (bmj.com)
  • The therapeutic role of coronary vasodilators: glyceryl trinitrate, isosorbide dinitrate, and pentaerythritol tetranitrate. (wikipedia.org)
  • isosorbide dinitrate, avanafil. (medscape.com)
  • In addition, Isosorbide Dinitrate should not be used if you have the following conditions: Alcohol, Allergic reactions, Anemia, Avanafil Brain hemorrhage, Head injury. (actizapharma.com)
  • Isosorbide dinitrate is in the nitrate family of medications and works by dilating blood vessels. (wikipedia.org)
  • Other medications included amlodipine, isosorbide-dinitrate and ASA (b -blockers were stopped because of COPD). (ispub.com)
  • The onset of action for Isosorbide Dinitrate is thirty minutes and the onset of action for oral extended release is 12-24 hours. (wikipedia.org)
  • Absorption of isosorbide dinitrate after oral dosing is nearly complete, but bioavailability is highly variable (10% to 90%), with extensive first-pass metabolism in the liver. (nih.gov)
  • Each Isosorbide Dinitrate Extended-release tablet, for oral administration, contains 40 mg of isosorbide dinitrate, in a matrix that causes the active drug to be released over a sustained period. (nih.gov)
  • The onset of action of controlled-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. (prescriptiondrugs.com)
  • The benefits of controlled-release oral isosorbide dinitrate in patients with acute myocardial infarction or congestive heart failure have not been established. (prescriptiondrugs.com)
  • Because the effects of controlled-release oral isosorbide dinitrate are so difficult to terminate rapidly, this formulation is not recommended in these settings. (prescriptiondrugs.com)
  • Characterization of Hemodynamic Response to Isosorbide Dinitrate Durin" by Douglas C. Anderson, S. R. Horton et al. (cedarville.edu)
  • If one elects to use isosorbide dinitrate in these conditions, careful clinical or hemodynamic monitoring must be used to avoid the hazards of hypotension and tachycardia. (prescriptiondrugs.com)
  • In the short run, isosorbide dinitrate can cause severe headaches, necessitating analgesic administration for relief of pain, as well as severe hypotension, and, in certain cases, bradycardia. (wikipedia.org)
  • The principal pharmacological action of isosorbide dinitrate is relaxation of vascular smooth muscle and consequent dilatation of peripheral arteries and veins, especially the latter. (nih.gov)
  • Isosorbide Dinitrate is used for Severe Chest Pain, Congestive Cardiac Failure and other conditions.Isosorbide Dinitrate improves the patient's condition by performing the following functions:Widening the blood vessels in the heart.If you use other drugs or over the counter products at the same time, the effects of Isosorbide Dinitrate may change. (actizapharma.com)
  • Objective To determine the effectiveness of isosorbide dinitrate in combination with tenoxicam compared with tenoxicam alone for the relief of acute renal colic. (inonu.edu.tr)
  • 1980. Acute and chronic propylene glycol dinitrate exposure in the monkey. (cdc.gov)
  • The following is a list of possible side-effects that may occur in medicines that contain Isosorbide Dinitrate. (actizapharma.com)
  • Isosorbide dinitrate is a white, crystalline, odorless compound which is stable in air and in solution, has a melting point of 70°C and has an optical rotation of +134° (c=1.0, alcohol, 20°C). Isosorbide dinitrate is freely soluble in organic solvents such as acetone, alcohol, and ether, but is only sparingly soluble in water. (nih.gov)
  • The chemical name for isosorbide dinitrate is 1,4:3,6-dianhydro-D-glucitol 2, 5-dinitrate, an organic nitrate whose structural formula is and whose molecular weight is 236.14. (prescriptiondrugs.com)
  • Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure. (naturalnews.com)
  • isosorbide dinitrate increases effects of cabergoline by decreasing metabolism. (medscape.com)
  • isosorbide dinitrate increases effects of ergoloid mesylates by decreasing metabolism. (medscape.com)
  • isosorbide dinitrate increases effects of ergotamine by decreasing metabolism. (medscape.com)
  • Isosorbide dinitrate is a medication used for heart failure, esophageal spasms, and to treat and prevent chest pain from not enough blood flow to the heart. (wikipedia.org)
  • Isosorbide dinitrate is available as a generic medication. (wikipedia.org)
  • apalutamide will decrease the level or effect of isosorbide dinitrate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. (medscape.com)
  • idelalisib will increase the level or effect of isosorbide dinitrate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. (medscape.com)
  • ivosidenib will decrease the level or effect of isosorbide dinitrate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. (medscape.com)
  • N-Acetyl-Cysteine - People taking isosorbide dinitrate might benefit from supplements of the amino acid N-acetyl-Cysteine. (naturalnews.com)
  • Once absorbed, the volume of distribution of isosorbide dinitrate is 2 to 4 L/kg, and this volume is cleared at the rate of 2 to 4 L/min, so ISDN's half-life in serum is about an hour. (nih.gov)